๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Selexipag - Medicines in Ireland

25 authorised products containing Selexipag, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 25 authorised medicines
MedicineActive substanceLicence holderStatus
Selexipag Accord 1 000 microgram film-coated tablets
PA2315/281/005
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Accord 1 200 microgram film-coated tablets
PA2315/281/006
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Accord 1 400 microgram film-coated tablets
PA2315/281/007
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Accord 1 600 microgram film-coated tablets
PA2315/281/008
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Accord 200 microgram film-coated tablets
PA2315/281/001
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Accord 400 microgram film-coated tablets
PA2315/281/002
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Accord 600 microgram film-coated tablets
PA2315/281/003
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Accord 800 microgram film-coated tablets
PA2315/281/004
Selexipag Accord Healthcare Ireland Ltd. Not marketed
Selexipag Clonmel 1000 microgram film-coated tablets
PA0126/394/005
Selexipag Clonmel Healthcare Ltd Not marketed
Selexipag Clonmel 1200 microgram film-coated tablets
PA0126/394/006
Selexipag Clonmel Healthcare Ltd Not marketed
Selexipag Clonmel 1400 microgram film-coated tablets
PA0126/394/007
Selexipag Clonmel Healthcare Ltd Not marketed
Selexipag Clonmel 1600 microgram film-coated tablets
PA0126/394/008
Selexipag Clonmel Healthcare Ltd Not marketed
Selexipag Clonmel 200 microgram film-coated tablets
PA0126/394/001
Selexipag Clonmel Healthcare Ltd Not marketed
Selexipag Clonmel 400 microgram film-coated tablets
PA0126/394/002
Selexipag Clonmel Healthcare Ltd Not marketed
Selexipag Clonmel 600 microgram film-coated tablets
PA0126/394/003
Selexipag Clonmel Healthcare Ltd Not marketed
Selexipag Clonmel 800 microgram film-coated tablets
PA0126/394/004
Selexipag Clonmel Healthcare Ltd Not marketed
Uptravi 100 microgram film-coated tablets
EU/1/15/1083/012-013
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1000 microgram film-coated tablets
EU/1/15/1083/007
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1200 microgram film-coated tablets
EU/1/15/1083/008
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1400 microgram film-coated tablets
EU/1/15/1083/009
Selexipag Janssen-Cilag International NV โ€”
Uptravi 1600 microgram film-coated tablets
EU/1/15/1083/010
Selexipag Janssen-Cilag International NV โ€”
Uptravi 200 microgram film-coated tablets
EU/1/15/1083/001-003
Selexipag Janssen-Cilag International NV โ€”
Uptravi 400 microgram film-coated tablets
EU/1/15/1083/004
Selexipag Janssen-Cilag International NV โ€”
Uptravi 600 microgram film-coated tablets
EU/1/15/1083/005
Selexipag Janssen-Cilag International NV โ€”
Uptravi 800 microgram film-coated tablets
EU/1/15/1083/006
Selexipag Janssen-Cilag International NV โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.